Effect of Detergents on Streptolysin S Precursor

od Calandra, Gary B.
Izdano 1980

Novel developments in stem cell mobilization focus on CXCR4 /

od Fruehauf, Stefan., Zeller, W. Jens., Calandra, Gary.
Izdano 2012

Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease

od Blum, Arnon, Childs, Richard W., Smith, Aleah, Patibandla, Sushmitha, Zalos, Gloria, Samsel, Leigh, McCoy, J. Philip, Calandra, Gary, Csako, Gyorgy, Cannon, Richard O.
Izdano 2009

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210

od Johnson, Victoria A., Cramer, Yoninah S., Rosenkranz, Susan L., Becker, Stephen, Klingman, Karin L., Kallungal, Beatrice, Coakley, Eoin, Acosta, Edward P., Calandra, Gary, Saag, Michael S.
izdano v AIDS Res Hum Retroviruses (2019)

Effect of high-dose plerixafor on CD34(+) cell mobilization in healthy stem cell donors: results of a randomized crossover trial

od Pantin, Jeremy, Purev, Enkhtsetseg, Tian, Xin, Cook, Lisa, Donohue-Jerussi, Theresa, Cho, Elena, Reger, Robert, Hsieh, Matthew, Khuu, Hanh, Calandra, Gary, Geller, Nancy L., Childs, Richard W.
izdano v Haematologica (2017)

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

od Lemery, Steven J., Hsieh, Matthew M., Smith, Aleah, Rao, Sheila, Khuu, Hanh M., Theresa, Donohue, Viano, Jennifer M., Cook, Lisa, Goodwin, Rose, Boss, Carol, Calandra, Gary, Geller, Nancy, Tisdale, John, Childs, Richard
Izdano 2011

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

od Broxmeyer, Hal E., Orschell, Christie M., Clapp, D. Wade, Hangoc, Giao, Cooper, Scott, Plett, P. Artur, Liles, W. Conrad, Li, Xiaxin, Graham-Evans, Barbara, Campbell, Timothy B., Calandra, Gary, Bridger, Gary, Dale, David C., Srour, Edward F.
Izdano 2005

Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

od Stone, Nimalie D., Dunaway, Shelia B., Flexner, Charles, Tierney, Camlin, Calandra, Gary B., Becker, Stephen, Cao, Ying-Jun, Wiggins, Ilene P., Conley, Jeanne, MacFarland, Ron T., Park, Jeong-Gun, Lalama, Christina, Snyder, Sally, Kallungal, Beatrice, Klingman, Karin L., Hendrix, Craig W.
Izdano 2007

Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

od Stone, Nimalie D., Dunaway, Shelia B., Flexner, Charles, Tierney, Camlin, Calandra, Gary B., Becker, Stephen, Cao, Ying-Jun, Wiggins, Ilene P., Conley, Jeanne, MacFarland, Ron T., Park, Jeong-Gun, Lalama, Christina, Snyder, Sally, Kallungal, Beatrice, Klingman, Karin L., Hendrix, Craig W.
Izdano 2007

Differences in the phenotype, cytokine gene expression profiles and in vivo alloreactivity of T cells mobilized with plerixafor compared to G-CSF

od Lundqvist, Andreas, Smith, Aleah L., Takahashi, Yoshiyuki, Wong, Susan, Bahceci, Erkut, Cook, Lisa, Ramos, Catalina, Tawab, Abdul, McCoy, J. Philip, Read, Elizabeth J., Khuu, Hanh M., Bolan, Charles D., Jungnam, Joo, Geller, Nancy, Leitman, Susan F., Calandra, Gary, Dunbar, Cynthia, Kurlander, Roger, Childs, Richard W.
Izdano 2013